Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
RADICAVA ORS® (edaravone)
(https://radicava.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE RADICAVA ORS® (edaravone) | Treatment & Support (https://radicava.com)
Title
RADICAVA ORS® (edaravone) | Treatment & Support
Meta
Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment.
H3 How Treatment Can Help
H3 Fitting Your Routine
H3 Getting Started
H3 The RADICAVA ORS® Educational Communications Series—Sign Up Today
H3 Important Safety Information
H3 Important Safety Information
H3 You are now leaving Radicava.com
NAV_HEADING_REPEATED_BODY RADICAVA ORS® (edaravone) | Treatment & Support (https://radicava.com/patient/)
Title
RADICAVA ORS® (edaravone) | Treatment & Support
Meta
Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment.
H3 How Treatment Can Help
H3 Fitting Your Routine
H3 Getting Started
H3 The RADICAVA ORS® Educational Communications Series—Sign Up Today
H3 Important Safety Information
H3 Important Safety Information
H3 You are now leaving Radicava.com
NAV_REPEATED_BODY Free ALS Webinars & Expert Videos (https://radicava.com/patient/educational-webinar/)
Title
Free ALS Webinars & Expert Videos
Meta
Watch neurologists and ALS specialists discuss RADICAVA ORS® (edaravone), disease management and emerging research in our on-demand webinars.
H1 Educational Webinars for People With ALS and Caregivers
H2 Understanding RADICAVA ORS® and How to Get Started
H2 Breaking Down Barriers: Understanding Access & Insurance Coverage for ALS Treatments
H2 Building a Strong Support Network for Your Journey With ALS
H2 My Experience With ALS and RADICAVA ORS®
H2 RADICAVA ORS®: Built on Solid Ground With Gwen Petersen and Gary L Pattee, MD
H2 Understanding Amyotrophic Lateral Sclerosis (ALS) with Dr. Jeffrey Rosenfeld, MD, PhD
H3 Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video.
H3 Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video.
H3 Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video.
H3 Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video.
H3 Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video.
H3 Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video.
H3 Want to receive information and resources about RADICAVA ORS®?
H3 Important Safety Information
H3 Important Safety Information
H3 You are now leaving Radicava.com
NAV_HEADING_REPEATED_BODY Why Choose RADICAVA ORS® (edaravone) for ALS? (https://radicava.com/patient/understanding-radicava/)
Title
Why Choose RADICAVA ORS® (edaravone) for ALS?
Meta
Review efficacy data, safety profile and patient support resources that make RADICAVA ORS® (edaravone) a treatment option for ALS.
H1 Why RADICAVA ORS® for ALS?
H2 What you should know
H2 RADICAVA ORS® Facts to Remember
H2 In ALS, Every Point Matters
H2 RADICAVA ORS®: Proven to Help Slow the Loss of Physical Function
H2 RADICAVA ORS® Is an Oral Treatment That Can Fit Into Your Routine
H3 RADICAVA ORS® is an oral form of RADICAVA®
H3 This chart shows that in the clinical study, the decline in physical function for patients who received RADICAVA® was 33% less than for those who received placebo at 24 weeks.
H3 Patients on RADICAVA® lost fewer points on the ALSFRS-R at 6 months. Fewer points lost means more function retained
H3 RADICAVA ORS® Was Generally Well Tolerated
H3 Fewer than 6% (11/185) of patients discontinued RADICAVA ORS® because of side effects in the 6-month safety study in 185 patients with ALS
H3 Why RADICAVA ORS®
H3 See How You Can Learn About Starting Treatment
H3 Important Safety Information
H3 Important Safety Information
H3 You are now leaving Radicava.com
H4 Side effect profile
H4 Make sure to tell your doctor:
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://radicava.com) RADICAVA ORS® (edaravone) | Treatment & Support
[IMG: RADICAVA ORS® (edaravone) logo with orange swoop] MENU [IMG: Icon Button Sign Up] SIGN UPMENU [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] [IMG: RADICAVA ORS® (edaravone) logo with orange swoop] [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] Why RADICAVA ORS® for ALS?RADICAVA ORS® Facts to RememberRADICAVA ORS® Was Generally Well ToleratedRADICAVA ORS® Is an Oral Treatment That Can Fit Into Your RoutineWhy RADICAVA ORS® for ALS?RADICAVA ORS® Journey GuideGet Treatment InformationFrequently Asked QuestionsConsidering RADICAVA ORS® FAQsDeciding on RADICAVA ORS® FAQsTaking RADICAVA ORS® FAQsEducational Webinars For ALS PatientsUnderstanding RADICAVA ORS® and How to Get StartedBreaking Down BarriersBuilding a Strong Support NetworkMy Experience With ALS and RADICAVA ORS®Built on Solid GroundUnderstanding ALS Video [IMG: Treatment Journey Icon] Get the information you need on your treatment journey.GO TO THE JOURNEY GUIDE [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] RADICAVA ORS® ExperiencesFilter Content by TopicShare Your StoryShare Your Story & Help Others In the ALS CommunityWatch a Share Your Story Video [IMG: TBD] Why RADICAVA ORS® for ALS?WATCH NOW [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] Starting RADICAVA ORS®Download Talk to Your Doctor Discussion GuideInvestigating your Benefits CoverageReceiving RADICAVA ORS®FAQs About Starting TreatmentFinancial Support OptionsOut-of-Pocket Assistance ProgramInformation About Government Health Plan OptionsResources for Patients Who Are UninsuredAlternate Support/Resource InformationUnderstanding Open Enrollment 2026ALS Care LocatorFind Treatment ProvidersSupport for Veterans With ALSDownload RADICAVA ORS® GuideLearn About VA BenefitsOther Resources for Veterans [IMG: TBD] RADICAVA ORS® is on the VA National FormularyLEARN MORE [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] JourneyMate Support Program™Core Team MembersJourneyMate Resource SpecialistHow They Can Help YouCall a JourneyMate Resource SpecialistUnderstanding ALSWhat Is ALS?Treatments for ALSIdeas for Living With ALSConnecting With Your Care TeamDownload Talk to Your Doctor Discussion GuideCaring for a Loved One With ALSCoping With BurnoutResourcesFor YouFor You & Your DoctorRecursos En Español [IMG: TBD] The RADICAVA ORS® Educational Communication SeriesSIGN UP [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] [IMG: Flip icon] [H3] How Treatment Can Help [IMG: How Treatment Can Help] REVIEW THE DATA [IMG: Flip icon] Learn how RADICAVA ORS® was proven to help slow the loss of physical function by 33% at 24 weeks.REVIEW THE DATA [IMG: Flip icon] [H3] Fitting Your Routine [IMG: Fitting Your Routine] HOW TO TAKE [IMG: Flip icon] See how RADICAVA ORS® can fit your routine with a 5 mL oral dose of a proven treatment.a,b (see footnote)HOW TO TAKE [IMG: Flip icon] [H3] Getting Started [IMG: Getting Started] SEE THE STEPS [IMG: Flip icon] Review how to start RADICAVA ORS®, questions to ask your doctor, financial support options, and more.SEE THE STEPS [IMG: Logo for JourneyMate Support Program™] No matter where you are in your ALS journey—from diagnosis to treatment—the JourneyMate Support Program™ gives you the understanding, answers, and resources to help you move forward. If you’re new to treatment, the program can help you learn more about RADICAVA ORS®.Learn more [H3] The RADICAVA ORS® Educational Communications Series—Sign Up Today Join our community of 18,000+ people who’ve signed up to learn more about RADICAVA ORS® and why it matters to patients and caregivers.LEARN MORE & SIGN UPHelp other people living with ALS by sharing your experience with ALS and RADICAVA ORS®. See how you can share aThe initial treatment cycle starts with daily dosing of RADICAVA ORS® for 14 days followed by a 14-day drug-free period. Subsequent treatment cycles include daily dosing 10 out of 14 days followed by a 14-day drug-free period. Return to content bUse the provided 5 mL syringe that comes with the product. Do not use a household teaspoon to measure your medication. Return to content
4395 chars
SUB-PAGE (https://radicava.com/patient/) RADICAVA ORS® (edaravone) | Treatment & Support
[IMG: RADICAVA ORS® (edaravone) logo with orange swoop] MENU [IMG: Icon Button Sign Up] SIGN UPMENU [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] [IMG: RADICAVA ORS® (edaravone) logo with orange swoop] [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] Why RADICAVA ORS® for ALS?RADICAVA ORS® Facts to RememberRADICAVA ORS® Was Generally Well ToleratedRADICAVA ORS® Is an Oral Treatment That Can Fit Into Your RoutineWhy RADICAVA ORS® for ALS?RADICAVA ORS® Journey GuideGet Treatment InformationFrequently Asked QuestionsConsidering RADICAVA ORS® FAQsDeciding on RADICAVA ORS® FAQsTaking RADICAVA ORS® FAQsEducational Webinars For ALS PatientsUnderstanding RADICAVA ORS® and How to Get StartedBreaking Down BarriersBuilding a Strong Support NetworkMy Experience With ALS and RADICAVA ORS®Built on Solid GroundUnderstanding ALS Video [IMG: Treatment Journey Icon] Get the information you need on your treatment journey.GO TO THE JOURNEY GUIDE [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] RADICAVA ORS® ExperiencesFilter Content by TopicShare Your StoryShare Your Story & Help Others In the ALS CommunityWatch a Share Your Story Video [IMG: TBD] Why RADICAVA ORS® for ALS?WATCH NOW [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] Starting RADICAVA ORS®Download Talk to Your Doctor Discussion GuideInvestigating your Benefits CoverageReceiving RADICAVA ORS®FAQs About Starting TreatmentFinancial Support OptionsOut-of-Pocket Assistance ProgramInformation About Government Health Plan OptionsResources for Patients Who Are UninsuredAlternate Support/Resource InformationUnderstanding Open Enrollment 2026ALS Care LocatorFind Treatment ProvidersSupport for Veterans With ALSDownload RADICAVA ORS® GuideLearn About VA BenefitsOther Resources for Veterans [IMG: TBD] RADICAVA ORS® is on the VA National FormularyLEARN MORE [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] JourneyMate Support Program™Core Team MembersJourneyMate Resource SpecialistHow They Can Help YouCall a JourneyMate Resource SpecialistUnderstanding ALSWhat Is ALS?Treatments for ALSIdeas for Living With ALSConnecting With Your Care TeamDownload Talk to Your Doctor Discussion GuideCaring for a Loved One With ALSCoping With BurnoutResourcesFor YouFor You & Your DoctorRecursos En Español [IMG: TBD] The RADICAVA ORS® Educational Communication SeriesSIGN UP [IMG: Previous] HAVE QUESTIONS? ASK A JOURNEYMATE RESOURCE SPECIALIST CALL 1-855-457-6968 [IMG: Next] [IMG: Flip icon] [H3] How Treatment Can Help [IMG: How Treatment Can Help] REVIEW THE DATA [IMG: Flip icon] Learn how RADICAVA ORS® was proven to help slow the loss of physical function by 33% at 24 weeks.REVIEW THE DATA [IMG: Flip icon] [H3] Fitting Your Routine [IMG: Fitting Your Routine] HOW TO TAKE [IMG: Flip icon] See how RADICAVA ORS® can fit your routine with a 5 mL oral dose of a proven treatment.a,b (see footnote)HOW TO TAKE [IMG: Flip icon] [H3] Getting Started [IMG: Getting Started] SEE THE STEPS [IMG: Flip icon] Review how to start RADICAVA ORS®, questions to ask your doctor, financial support options, and more.SEE THE STEPS [IMG: Logo for JourneyMate Support Program™] No matter where you are in your ALS journey—from diagnosis to treatment—the JourneyMate Support Program™ gives you the understanding, answers, and resources to help you move forward. If you’re new to treatment, the program can help you learn more about RADICAVA ORS®.Learn more [H3] The RADICAVA ORS® Educational Communications Series—Sign Up Today Join our community of 18,000+ people who’ve signed up to learn more about RADICAVA ORS® and why it matters to patients and caregivers.LEARN MORE & SIGN UPHelp other people living with ALS by sharing your experience with ALS and RADICAVA ORS®. See how you can share aThe initial treatment cycle starts with daily dosing of RADICAVA ORS® for 14 days followed by a 14-day drug-free period. Subsequent treatment cycles include daily dosing 10 out of 14 days followed by a 14-day drug-free period. Return to content bUse the provided 5 mL syringe that comes with the product. Do not use a household teaspoon to measure your medication. Return to content
4395 chars
SUB-PAGE (https://radicava.com/patient/educational-webinar/) Free ALS Webinars & Expert Videos
[IMG: RADICAVA ORS® (edaravone) logo with orange swoop] MENU [IMG: Icon Button Sign Up] SIGN UPMENURADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968. [IMG: RADICAVA ORS® (edaravone) logo with orange swoop] RADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.Why RADICAVA ORS® for ALS?RADICAVA ORS® Facts to RememberRADICAVA ORS® Was Generally Well ToleratedRADICAVA ORS® Is an Oral Treatment That Can Fit Into Your RoutineWhy RADICAVA ORS® for ALS?RADICAVA ORS® Journey GuideGet Treatment InformationFrequently Asked QuestionsConsidering RADICAVA ORS® FAQsDeciding on RADICAVA ORS® FAQsTaking RADICAVA ORS® FAQsEducational Webinars For ALS PatientsUnderstanding RADICAVA ORS® and How to Get StartedBreaking Down BarriersBuilding a Strong Support NetworkMy Experience With ALS and RADICAVA ORS®Built on Solid GroundUnderstanding ALS Video [IMG: Treatment Journey Icon] Get the information you need on your treatment journey.GO TO THE JOURNEY GUIDERADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.RADICAVA ORS® ExperiencesFilter Content by TopicShare Your StoryShare Your Story & Help Others In the ALS CommunityWatch a Share Your Story Video [IMG: TBD] Why RADICAVA ORS® for ALS?WATCH NOWRADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.Starting RADICAVA ORS®Download Talk to Your Doctor Discussion GuideInvestigating your Benefits CoverageReceiving RADICAVA ORS®FAQs About Starting TreatmentFinancial Support OptionsOut-of-Pocket Assistance ProgramInformation About Government Health Plan OptionsResources for Patients Who Are UninsuredAlternate Support/Resource InformationUnderstanding Open Enrollment 2026ALS Care LocatorFind Treatment ProvidersSupport for Veterans With ALSDownload RADICAVA ORS® GuideLearn About VA BenefitsOther Resources for Veterans [IMG: TBD] RADICAVA ORS® is on the VA National FormularyLEARN MORERADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.JourneyMate Support Program™Core Team MembersJourneyMate Resource SpecialistHow They Can Help YouCall a JourneyMate Resource SpecialistUnderstanding ALSWhat Is ALS?Treatments for ALSIdeas for Living With ALSConnecting With Your Care TeamDownload Talk to Your Doctor Discussion GuideCaring for a Loved One With ALSCoping With BurnoutResourcesFor YouFor You & Your DoctorRecursos En Español [IMG: TBD] The RADICAVA ORS® Educational Communication SeriesSIGN UPRADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968. [H1] Educational Webinars for People With ALS and Caregivers These educational webinars feature a range of topics to help patients and caregivers learn more about their treatment options. If you have questions about ALS or RADICAVA ORS® (edaravone), call a JourneyMate Specialist for answers toll-free at 1-855-457-6968. [H2] Understanding RADICAVA ORS® and How to Get Started Moderators Dr Martina Wiedau and Alissa Nagler will walk you through details about RADICAVA ORS®, including what the medication is, how it may help, and what to expect during your treatment journey. [H3] Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video. LEARN MOREUnderstanding RADICAVA ORS® and How to Get Started [H2] Breaking Down Barriers: Understanding Access & Insurance Coverage for ALS Treatments Host and insurance and access expert Eric Johnston, PALS Chris Spaulding, and CALS Jayme Floyd will share their experience and guidance on helpful topics like obtaining insurance coverage for treatment and identifying resources to help reduce out-of-pocket costs. [H3] Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video. LEARN MOREBreaking Down Barriers: Understanding Access & Insurance Coverage for ALS Treatments [H2] Building a Strong Support Network for Your Journey With ALS Host and ALS caregiver advocate Jodi O’Donnell-Ames joins patient advocate David Buseck and caregiver Linda Levine to share insights and practical advice on building a strong personal support system for people navigating the ALS journey. [H3] Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video. LEARN MOREBuilding a Strong Support Network for Your Journey With ALS [H2] My Experience With ALS and RADICAVA ORS® Hear the personal accounts of life with ALS and treatment with RADICAVA ORS® from 2 people living with ALS. Moderated by an ALS advocate and volunteer, these panelists share their personal advice and perspectives on navigating their journeys with ALS. [H3] Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video. LEARN MOREMy Experience With ALS and RADICAVA ORS® [H2] RADICAVA ORS®: Built on Solid Ground With Gwen Petersen and Gary L Pattee, MD Learn more about the clinical evidence and data behind a proven treatment, and hear from a patient advocate about her own personal experience with RADICAVA ORS®. [H3] Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video. LEARN MORERADICAVA ORS®: Built on Solid Ground With Gwen Petersen and Gary L Pattee, MD [H2] Understanding Amyotrophic Lateral Sclerosis (ALS) with Dr. Jeffrey Rosenfeld, MD, PhD [H3] Review helpful information about RADICAVA ORS® and watch the Why RADICAVA ORS® video. LEARN MOREUnderstanding Amyotrophic Lateral Sclerosis (ALS) with Dr. Jeffrey Rosenfeld, MD, PhD Videos are sponsored by Tanabe Pharma America, Inc. (TPA). The speakers are presenting on behalf of, and have received compensation from TPA. Webinars are intended for general information purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. Patients are always encouraged to talk to their doctor or other qualified healthcare provider with any questions regarding a medical condition. It is important to discuss any insurance-related questions with your healthcare provider and insurance provider. Please see Important Safety Information below and click here for full Prescribing Information and Patient Information. Hear from other PALS and CALSWatch real peoples' videos and read written stories about their experiences with ALS and RADICAVA ORS®.LEARN MORE [IMG: Share your story logo] [IMG: CTA icon] Have questions about starting treatment?A JourneyMate Resource Specialist is ready to help you find information and educational resources about ALS and RADICAVA ORS® as you move forward on your journey with ALS. Call toll-free 1-855-457-6968 between 9 AM and 9 PM ET, Monday through Friday.Learn more [IMG: CTA Image] [H3] Want to receive information and resources about RADICAVA ORS®? SIGN UP HERE
6900 chars
SUB-PAGE (https://radicava.com/patient/understanding-radicava/) Why Choose RADICAVA ORS® (edaravone) for ALS?
[IMG: RADICAVA ORS® (edaravone) logo with orange swoop] MENU [IMG: Icon Button Sign Up] SIGN UPMENURADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968. [IMG: RADICAVA ORS® (edaravone) logo with orange swoop] RADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.Why RADICAVA ORS® for ALS?RADICAVA ORS® Facts to RememberRADICAVA ORS® Was Generally Well ToleratedRADICAVA ORS® Is an Oral Treatment That Can Fit Into Your RoutineWhy RADICAVA ORS® for ALS?RADICAVA ORS® Journey GuideGet Treatment InformationFrequently Asked QuestionsConsidering RADICAVA ORS® FAQsDeciding on RADICAVA ORS® FAQsTaking RADICAVA ORS® FAQsEducational Webinars For ALS PatientsUnderstanding RADICAVA ORS® and How to Get StartedBreaking Down BarriersBuilding a Strong Support NetworkMy Experience With ALS and RADICAVA ORS®Built on Solid GroundUnderstanding ALS Video [IMG: Treatment Journey Icon] Get the information you need on your treatment journey.GO TO THE JOURNEY GUIDERADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.RADICAVA ORS® ExperiencesFilter Content by TopicShare Your StoryShare Your Story & Help Others In the ALS CommunityWatch a Share Your Story Video [IMG: TBD] Why RADICAVA ORS® for ALS?WATCH NOWRADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.Starting RADICAVA ORS®Download Talk to Your Doctor Discussion GuideInvestigating your Benefits CoverageReceiving RADICAVA ORS®FAQs About Starting TreatmentFinancial Support OptionsOut-of-Pocket Assistance ProgramInformation About Government Health Plan OptionsResources for Patients Who Are UninsuredAlternate Support/Resource InformationUnderstanding Open Enrollment 2026ALS Care LocatorFind Treatment ProvidersSupport for Veterans With ALSDownload RADICAVA ORS® GuideLearn About VA BenefitsOther Resources for Veterans [IMG: TBD] RADICAVA ORS® is on the VA National FormularyLEARN MORERADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968.JourneyMate Support Program™Core Team MembersJourneyMate Resource SpecialistHow They Can Help YouCall a JourneyMate Resource SpecialistUnderstanding ALSWhat Is ALS?Treatments for ALSIdeas for Living With ALSConnecting With Your Care TeamDownload Talk to Your Doctor Discussion GuideCaring for a Loved One With ALSCoping With BurnoutResourcesFor YouFor You & Your DoctorRecursos En Español [IMG: TBD] The RADICAVA ORS® Educational Communication SeriesSIGN UPRADICAVA ORS® is a MAJOR CONTRIBUTION TO PATIENT CARE Call a JourneyMate Resource Specialist at 1-855-457-6968. [H1] Why RADICAVA ORS® for ALS? RADICAVA ORS® (edaravone) is proven to help slow the loss of physical function in people with amyotrophic lateral sclerosis (ALS). [H2] What you should know [IMG: 1] Nonfamilial (sporadic) ALS doesn’t have a known family or genetic cause, and makes up about 90% of ALS cases in the US.a (see footnote) [IMG: 2] As of 2025, there are only 2 available treatments in the US for nonfamilial ALS: riluzole and edaravone. [IMG: 3] Your doctor may prescribe both RADICAVA ORS® and riluzole. Talk to your doctor about the right treatment option for you. [IMG: Why RADICAVA ORS video thumbnail] [IMG: Icon Website] Get the information you need on your treatment journey. Go to the RADICAVA ORS® Journey Guide [H2] RADICAVA ORS® Facts to Remember [IMG: Patients icon] RADICAVA ORS® was recognized in 2024 as a major contribution to patient care* [IMG: ORS icon] 16,100+ people have been treated with RADICAVA ORS® since 2022 for 1.7 million+ days of therapyb,c (see footnote) [IMG: Study icon] The safety and tolerability of RADICAVA has been studied in 500+ people across multiple clinical studies *RADICAVA ORS® can be taken orally (by mouth), which is a less burdensome option than intravenous (IV) administration.d (see footnote) bBased on RADICAVA ORS® prescriptions submitted in the US as of January 2026. Not independently verified. [IMG: divider] [H2] In ALS, Every Point Matters The pivotal phase 3 clinical trial of RADICAVA® was specifically designed to measure change in physical function assessed by the ALSFRS-R.The sooner you start treatment, the sooner you may begin slowing the loss of physical function. [H2] RADICAVA ORS®: Proven to Help Slow the Loss of Physical Function [H3] RADICAVA ORS® is an oral form of RADICAVA® In the clinical study, RADICAVA® slowed the loss of physical function, as measured by the ALSFRS-R. [IMG: RADICAVA® (edaravone) efficacy graph] [IMG: RADICAVA® (edaravone) efficacy graph] [H3] This chart shows that in the clinical study, the decline in physical function for patients who received RADICAVA® was 33% less than for those who received placebo at 24 weeks. LEARN MORE ABOUT THE ALSFRS-R [IMG: Woman reading chart] [H3] Patients on RADICAVA® lost fewer points on the ALSFRS-R at 6 months. Fewer points lost means more function retained 3X as many patients given RADICAVA lost 2 or less points (39.1% RADICAVA vs 13.2% placebo) [IMG: TBD] 3X as many patients given placebo lost 11 or less points (23.5% placebo vs 7.2% RADICAVA) [IMG: TBD] A similar number of patients in both treatment arms lost 3 to 10 points (37/69 with RADICAVA and 43/68 with placebo) Over 90% of patients in each group were also being treated with riluzole Your doctor may prescribe RADICAVA ORS® in addition to riluzole—the only approved treatments for nonfamilial ALS. [IMG: TBD] [IMG: TBD] There are 3 reasons why I take RADICAVA ORS®. One, my neurologist and I feel the data is compelling. Two, it’s accessible. And three, the administration fits into my lifestyle. - Gwen, Patient Advocate & Paid Consultant [IMG: divider] [H3] RADICAVA ORS® Was Generally Well Tolerated [H4] Side effect profile The safety profile of RADICAVA® was evaluated in multiple placebo-controlled studies in 184 patients with ALSRADICAVA ORS® was generally well tolerated in a 6-month clinical study of 185 patients with ALSCommon side effects reported include bruising (contusion), problems walking (gait disturbance), headache and fatigue. These are not all the possible side effects of RADICAVA ORS®. [H3] Fewer than 6% (11/185) of patients discontinued RADICAVA ORS® because of side effects in the 6-month safety study in 185 patients with ALS Approximately 1% (2/185) of patients discontinued RADICAVA ORS® due to gastrointestinal side effects (diarrhea and trouble swallowing)Other reasons for discontinuation in ~1% (2/185) of patients included respiratory failure and muscular weaknessBe sure to tell your doctor if you are allergic to other medications and share all of the medications you are taking. The safety profiles of RADICAVA ORS® and RADICAVA® were established in 500+ patients with ALS in multiple clinical studies. RADICAVA ORS® may cause serious side effects including hypersensitivity (allergic) reactions and sulfite allergic reactions. [H4] Make sure to tell your doctor: [IMG: Icon Asthma] If you have asthma [IMG: Icon Medication] If you are allergic to other medications [IMG: Icon Pregnant] If you are pregnant or intend to become pregnant [IMG: Icon Feeding] If you are breastfeeding or intend to breastfeed [IMG: Icon Medicine] All of the medications you are takingPlease see additional Important Safety Information. [H2] RADICAVA ORS® Is an Oral Treatment That Can Fit Into Your Routine [IMG: Icon Asthma] Can be taken orally (by mouth) or via feeding tube [IMG: Icon Medication] 5 mL oral dose may take only a few minutes to administer on treatment dayse (see footnote) [IMG: Icon Pregnant] Stored at room temperature so you can take it at home or on the gof (see footnote) [IMG: Icon Pregnant] Requires shaking but does not require water or additional mixing steps [IMG: TBD] [IMG: TBD] One thing I really like about RADICAVA ORS® is how it fits into my routine. - Stephanie, living with ALS [IMG: divider] [H3] Why RADICAVA ORS® Watch this video explaining how RADICAVA ORS® was shown to treat people with ALS. [IMG: Why RADICAVA ORS video thumbnail] [IMG: TBD] [IMG: TBD] When it came to RADICAVA, I extensively researched any information available and had in-depth discussions with my neurologist and we decided it was the right choice for me. - Juan, living with ALS [H3] See How You Can Learn About Starting Treatment [IMG: How Radicava may help video thumbnail] aNational Institute of Neurological Disorders and Stroke. Amyotrophic lateral sclerosis (ALS). https://www.ninds.nih.gov/health-information/disorders/amyotrophic-lateral-sclerosis-als. Return to content cDays of therapy based on number of Starter Kit and Maintenance Kit cartons sold for RADICAVA ORS® as of January 2026. Each Starter Kit includes 14 days of therapy, and each Maintenance Kit includes 10 days of therapy. Return to content dUS Food and Drug Administration. Clinical superiority findings. https://www.fda.gov/industry/designating-orphan-product-drugs-and-biological-products/clinical-superiority-findings. Return to content eUse the provided 5 mL syringe that comes with the product. Do not use a household teaspoon to measure your medication. Return to content fStore RADICAVA ORS® upright at room temperature between 68ºF and 77ºF. Protect from light. Return to content ALSFRS-R=ALS Functional Rating Scale–Revised; FDA=Food and Drug Administration; IV=intravenous.
9494 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
20Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 5 | 0 |
| /patient/ | 5 | 0 |
| /patient/educational-webinar/ | 6 | 0 |
| /patient/understanding-radicava/ | 4 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment."
}
/patient/
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment."
}
/patient/educational-webinar/
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/educational-webinar/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Watch neurologists and ALS specialists discuss RADICAVA ORS® (edaravone), disease management and emerging research in our on-demand webinars."
}
/patient/understanding-radicava/
{
"@context": "https://schema.org",
"@type": "Organization",
"url": "https://www.radicava.com/patient/understanding-radicava/",
"logo": "https://www.radicava.com/logo_radicava_ors.svg",
"name": "RADICAVA ORS® (edaravone)",
"description": "Review efficacy data, safety profile and patient support resources that make RADICAVA ORS® (edaravone) a treatment option for ALS."
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
BS Detector
Medical Devices, Pharma & Biotech BS: RADICAVA ORS® (edaravone) (radicava.com)
https://radicava.com
📍 Industry: Medical Devices, Pharma & Biotech
22
BS / 100
This is a high-substance, low-BS pharmaceutical site that substitutes traditional marketing fluff with rigorous, regulatory-compliant repetition. While it leans into ‘Patient Journey’ theater, it anchors every emotional appeal to specific clinical trial data and quantified functional metrics.
Info Density
Power-words vs. Substance ratio.
6
20% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
11
55% BS
Commodity Fingerprint
Detection of industry clichés/templates.
2
13% BS
Identity & Authority
Expert verifiability & Schema depth.
3
20% BS
To reduce the BS score, implement Person schema for all named medical experts and include sameAs links to their professional credentials. Replace the repeated banner slogan with page-specific value propositions to reduce concept repetition points. Provide direct outbound links to ClinicalTrials.gov or PubMed for the cited studies to transition from internal footnotes to external proof paths. Include a sameAs link in the Organization schema to the parent company’s corporate identity.
The website perfectly aligns with the Pharma & Biotech industry, specifically focusing on the therapeutic area of Amyotrophic Lateral Sclerosis (ALS). The content is heavily structured around regulatory requirements, safety information, and clinical trial data, which are core expectations for this category.
“The score of 22 is driven mostly by the trust_theatre_flag and high concept repetition. The presence of unverified testimonials from paid consultants and the lack of structured data for named experts are the only significant 'BS' indicators on an otherwise data-dense site.”
Verified Analysis Date: June 19, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from RADICAVA ORS® (edaravone), captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to RADICAVA ORS® (edaravone): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://radicava.com to view the most current version of its content and learn from the source what this company is about and what it offers.